HCA Healthcare, Inc. (NYSE:HCA) Position Raised by Toronto Dominion Bank

Toronto Dominion Bank lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 134.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,811 shares of the company's stock after purchasing an additional 130,076 shares during the quarter. Toronto Dominion Bank owned about 0.09% of HCA Healthcare worth $68,076,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of HCA. GF Fund Management CO. LTD. purchased a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,395,000. University of Texas Texas AM Investment Management Co. lifted its position in shares of HCA Healthcare by 56.7% during the 4th quarter. University of Texas Texas AM Investment Management Co. now owns 7,315 shares of the company's stock valued at $2,196,000 after acquiring an additional 2,646 shares during the period. Public Employees Retirement System of Ohio purchased a new position in HCA Healthcare in the 4th quarter valued at approximately $25,674,000. Neo Ivy Capital Management acquired a new position in shares of HCA Healthcare during the 4th quarter worth $361,000. Finally, Sunbelt Securities Inc. raised its position in HCA Healthcare by 3.4% during the fourth quarter. Sunbelt Securities Inc. now owns 2,457 shares of the company's stock worth $733,000 after acquiring an additional 80 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 0.1%

HCA stock traded up $0.29 during midday trading on Thursday, reaching $378.73. 1,449,079 shares of the company's stock traded hands, compared to its average volume of 1,440,406. The business has a 50-day moving average price of $349.48 and a two-hundred day moving average price of $329.96. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market capitalization of $91.11 billion, a P/E ratio of 17.24, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company's revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $5.36 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's payout ratio is 12.81%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on HCA shares. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their target price for the company from $320.00 to $385.00 in a research note on Thursday. Royal Bank of Canada cut their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Baird R W downgraded shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Robert W. Baird reaffirmed a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $385.47.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.